This is Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US More: New US nod for Roche's Tecentriq in NSCLC Source: News
read moreThe proposals would enable pharmacists to amend the strength and formulation of the medicine dispensed or supply a generic alternative More: Pharmacists should have greater powers to ensure meds access, says RPS Source: News
read moreA 19-page letter to the Prime Minister details ten key lessons the UK government should learn from its experience of handling the pandemic so far More: UK's coronavirus testing capacity has been 'inadequate', Committee finds Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals